The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016.

Jocelyn MoyesStefano TempiaSibongile WalazaMeredith L McMorrowFlorette TreurnichtNicole WolterAnne von GottbergKathleen KahnAdam L CohenHalima DawoodEbrahim VariavaCheryl Cohen

Published in: BMC medicine (2023)

Due to the high burden of RSV-associated illness, specifically SARI cases in young infants, maternal vaccination and monoclonal antibody products delivered at birth could prevent significant RSV-associated disease burden.

Keyphrases

monoclonal antibody
respiratory syncytial virus
south africa
respiratory tract
young adults
risk factors
pregnancy outcomes
physical activity
gestational age
weight loss
body mass index
birth weight
human immunodeficiency virus